Oxidation of Flavone, 5-Hydroxyflavone, and 5,7-Dihydroxyflavone to Mono-, Di-, and Tri-Hydroxyflavones by Human Cytochrome P450 Enzymes.


Journal

Chemical research in toxicology
ISSN: 1520-5010
Titre abrégé: Chem Res Toxicol
Pays: United States
ID NLM: 8807448

Informations de publication

Date de publication:
17 06 2019
Historique:
pubmed: 10 4 2019
medline: 14 4 2020
entrez: 10 4 2019
Statut: ppublish

Résumé

Biologically active plant flavonoids, including 5,7-dihydroxyflavone (57diOHF, chrysin), 4',5,7-trihydroxyflavone (4'57triOHF, apigenin), and 5,6,7-trihydroxyflavone (567triOHF, baicalein), have important pharmacological and toxicological significance, e.g., antiallergic, anti-inflammatory, antioxidative, antimicrobial, and antitumorgenic properties. In order to better understand the metabolism of these flavonoids in humans, we examined the oxidation of flavone, 5-hydroxyflavone (5OHF), and 57diOHF to various products by human cytochrome P450 (P450 or CYP) and liver microsomal enzymes. Individual human P450s and liver microsomes oxidized flavone to 6-hydroxyflavone, small amounts of 5OHF, and 11 other monohydroxylated products at different rates and also produced several dihydroxylated products (including 57diOHF and 7,8-dihydroxyflavone) from flavone. We also found that 5OHF was oxidized by several P450 enzymes and human liver microsomes to 57diOHF and further to 567triOHF, but the turnover rates in these reactions were low. Interestingly, both CYP1B1.1 and 1B1.3 converted 57diOHF to 567triOHF at turnover rates (on the basis of P450 contents) of >3.0 min

Identifiants

pubmed: 30964977
doi: 10.1021/acs.chemrestox.9b00078
doi:

Substances chimiques

Flavones 0
Flavonoids 0
chrysin 3CN01F5ZJ5
5-hydroxyflavone 491-78-1
Cytochrome P-450 Enzyme System 9035-51-2
flavone S2V45N7G3B

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1268-1280

Subventions

Organisme : NIGMS NIH HHS
ID : R01 GM118122
Pays : United States

Auteurs

Haruna Nagayoshi (H)

Osaka Institute of Public Health , 1-3-69 Nakamichi , Higashinari-ku , Osaka 537-0025 , Japan.

Norie Murayama (N)

Laboratory of Drug Metabolism and Pharmacokinetics , Showa Pharmaceutical University , Machida , Tokyo 194-8543 , Japan.

Kensaku Kakimoto (K)

Osaka Institute of Public Health , 1-3-69 Nakamichi , Higashinari-ku , Osaka 537-0025 , Japan.

Masaki Tsujino (M)

Osaka Institute of Public Health , 1-3-69 Nakamichi , Higashinari-ku , Osaka 537-0025 , Japan.

Shigeo Takenaka (S)

Graduate School of Comprehensive Rehabilitation , Osaka Prefecture University , 3-7-30 , Habikino , Osaka 583-8555 , Japan.

Jun Katahira (J)

Laboratory of Cellular and Molecular Biology, Veterinary Sciences , Osaka Prefecture University , 1-58 Rinku-Orai-Kita , Izumisano , Osaka 598-8531 , Japan.

Young-Ran Lim (YR)

Department of Biological Sciences , Konkuk University , Seoul 05029 , Korea.

Donghak Kim (D)

Department of Biological Sciences , Konkuk University , Seoul 05029 , Korea.

Hiroshi Yamazaki (H)

Laboratory of Drug Metabolism and Pharmacokinetics , Showa Pharmaceutical University , Machida , Tokyo 194-8543 , Japan.

Masayuki Komori (M)

Laboratory of Cellular and Molecular Biology, Veterinary Sciences , Osaka Prefecture University , 1-58 Rinku-Orai-Kita , Izumisano , Osaka 598-8531 , Japan.

F Peter Guengerich (FP)

Department of Biochemistry , Vanderbilt University School of Medicine , Nashville , Tennessee 37232-0146 , United States.

Tsutomu Shimada (T)

Laboratory of Cellular and Molecular Biology, Veterinary Sciences , Osaka Prefecture University , 1-58 Rinku-Orai-Kita , Izumisano , Osaka 598-8531 , Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH